This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2000 May;15(5):561-5.

doi: 10.1093/ndt/15.5.561.

ACE inhibitors and AT(1) receptor antagonists-beyond the haemodynamic effect

M Ruiz-Ortega, O Lorenzo, M Ruperez, J Egido

PMID: 10809789
DOI: 10.1093/ndt/15.5.561

Review

ACE inhibitors and AT(1) receptor antagonists-beyond the haemodynamic effect

M Ruiz-Ortega et al. Nephrol Dial Transplant. 2000 May.

. 2000 May;15(5):561-5.

doi: 10.1093/ndt/15.5.561.

Authors

M Ruiz-Ortega, O Lorenzo, M Ruperez, J Egido

PMID: 10809789
DOI: 10.1093/ndt/15.5.561

No abstract available

PubMed Disclaimer

Similar articles

Are angiotensin II receptor blockers superior to angiotensin converting enzyme inhibitors with regard to their renoprotective effect?
Geiger H. Geiger H. Nephrol Dial Transplant. 1997 Apr;12(4):640-2. doi: 10.1093/ndt/12.4.640. Nephrol Dial Transplant. 1997. PMID: 9140983 Review. No abstract available.
Angiotensin II type-I receptor antagonists in the treatment of heart failure.
Nicholls MG, Crozier IG, Ikram H, Richards AM. Nicholls MG, et al. Int J Cardiol. 1997 Dec 1;62 Suppl 1:S13-7. doi: 10.1016/s0167-5273(97)00207-6. Int J Cardiol. 1997. PMID: 9464577 Review. No abstract available.
[Angiotensin II type-1-receptor antagonists from the viewpoint of nephrology].
Hauser AC, Hörl WH. Hauser AC, et al. Wien Med Wochenschr. 2001;151(7-8):160-4. Wien Med Wochenschr. 2001. PMID: 11450164 Review. German.
Blood pressure drugs with bonus benefits. Both ACE inhibitors and ARBs also help stave off complications from heart failure and kidney disease.
[No authors listed] [No authors listed] Harv Heart Lett. 2014 Oct;25(2):5. Harv Heart Lett. 2014. PMID: 26027023 Review. No abstract available.
ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
Murdoch DR, McDonagh TA, Farmer R, Morton JJ, McMurray JJ, Dargie HJ. Murdoch DR, et al. Am Heart J. 2001 May;141(5):800-7. doi: 10.1067/mhj.2001.114802. Am Heart J. 2001. PMID: 11320369 Clinical Trial.

See all similar articles

Cited by

Trends in advanced glycation end products research in diabetes mellitus and its complications.
Méndez JD, Xie J, Aguilar-Hernández M, Méndez-Valenzuela V. Méndez JD, et al. Mol Cell Biochem. 2010 Aug;341(1-2):33-41. doi: 10.1007/s11010-010-0434-5. Epub 2010 Mar 23. Mol Cell Biochem. 2010. PMID: 20309613 Review.
Antiapoptotic effect of angiotensin-II type-1 receptor blockade in renal tubular cells of hyperoxaluric rats.
Tunçdemir M, Demirkesen O, Oztürk M, Atukeren P, Gümüştaş MK, Turan T. Tunçdemir M, et al. Urol Res. 2010 Apr;38(2):71-80. doi: 10.1007/s00240-010-0255-8. Epub 2010 Feb 12. Urol Res. 2010. PMID: 20151116
Should Renal Inflammation Be Targeted While Treating Hypertension?
Chaudhari S, Pham GS, Brooks CD, Dinh VQ, Young-Stubbs CM, Shimoura CG, Mathis KW. Chaudhari S, et al. Front Physiol. 2022 Jun 13;13:886779. doi: 10.3389/fphys.2022.886779. eCollection 2022. Front Physiol. 2022. PMID: 35770194 Free PMC article. Review.
ACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysm.
Kortekaas KE, Meijer CA, Hinnen JW, Dalman RL, Xu B, Hamming JF, Lindeman JH. Kortekaas KE, et al. PLoS One. 2014 Dec 4;9(12):e111952. doi: 10.1371/journal.pone.0111952. eCollection 2014. PLoS One. 2014. PMID: 25474105 Free PMC article.
Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.
Falcone C, Buzzi MP, Bozzini S, Boiocchi C, D'Angelo A, Schirinzi S, Esposito C, Torreggiani M, Choi J, Ochan Kilama M, Mancia G. Falcone C, et al. Mediators Inflamm. 2012;2012:874149. doi: 10.1155/2012/874149. Epub 2012 Feb 13. Mediators Inflamm. 2012. PMID: 22474401 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal